Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Other financing activities (2021 - 2025)

P3 Health Partners (PIII) has disclosed Other financing activities for 3 consecutive years, with -$7000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other financing activities fell 107.0% year-over-year to -$7000.0, compared with a TTM value of $177000.0 through Sep 2025, up 77.0%, and an annual FY2024 reading of $103000.0, down 40.46% over the prior year.
  • Other financing activities was -$7000.0 for Q3 2025 at P3 Health Partners, down from $42000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $6.4 million in Q2 2021 and bottomed at -$6.3 million in Q3 2021.
  • Average Other financing activities over 3 years is $72444.4, with a median of $42000.0 recorded in 2025.
  • Peak annual rise in Other financing activities hit 107.0% in 2025, while the deepest fall reached 107.0% in 2025.
  • Year by year, Other financing activities stood at $7972.0 in 2021, then plummeted by 62.37% to $3000.0 in 2024, then tumbled by 333.33% to -$7000.0 in 2025.
  • Business Quant data shows Other financing activities for PIII at -$7000.0 in Q3 2025, $42000.0 in Q2 2025, and $139000.0 in Q1 2025.